- Home
- XNCR vs NVGS Comparison
XNCR vs NVGS Comparison
Compare XNCR & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | NVGS |
|---|---|---|
| Founded | 1997 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | XNCR | NVGS |
|---|---|---|
| Price | $16.76 | $17.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $22.44 | $21.50 |
| AVG Volume (30 Days) | ★ 702.8K | 295.8K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 1.58% |
| EPS Growth | N/A | ★ 33.99 |
| EPS | N/A | ★ 1.50 |
| Revenue | $150,132,000.00 | ★ $578,158,000.00 |
| Revenue This Year | $18.81 | $2.77 |
| Revenue Next Year | N/A | $0.18 |
| P/E Ratio | ★ N/A | $11.82 |
| Revenue Growth | ★ 38.16 | 2.46 |
| 52 Week Low | $6.92 | $10.55 |
| 52 Week High | $26.59 | $18.29 |
Technical Indicators
Market Signals| Indicator | XNCR | NVGS |
|---|---|---|
| Relative Strength Index (RSI) | 56.12 | 49.30 |
| Support Level | $15.69 | $17.68 |
| Resistance Level | $18.69 | $18.07 |
| Average True Range (ATR) | 0.99 | 0.43 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 43.81 | 13.21 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.